SMTL ID : 4m8h.1

CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (R)4-METHYL 9cUAB30 AND COACTIVATOR PEPTIDE GRIP-1

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

hetero-oligomer

Ligands

1 x R4M: (2E,6Z,8E)-3,7-DIMETHYL-8-[(4R)-4-METHYL-3,4-DIHYDRONAPHTHALEN-1(2H)-YLIDENE]OCTA-2,6-DIENOIC ACID(Non-covalent)

R4M.1: 15 residues within 4Å: Chain A: I.41, A.44, A.45, Q.48, W.78, N.79, L.82, F.86, R.89, L.99, A.100, V.115, F.119, C.205, F.212 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:I.41, A:A.44, A:A.45, A:Q.48, A:W.78, A:N.79, A:L.82, A:F.86, A:F.86, A:V.115, A:F.119, A:F.212 Hydrogen bonds: A:A.44, A:A.100 Water bridges: A:F.86 Salt bridges: A:R.89

Links

RCSB   PDBe   PDBj   PDBsum   CATH   PLIP

Citation

Desphande, A. et al., Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention. Bioorg.Med.Chem. (2014)

Release Date

2014-01-22

Peptides

Retinoic acid receptor RXR-alpha: A
Nuclear receptor coactivator 2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Retinoic acid receptor RXR-alpha

Nuclear receptor coactivator 2

Related Entries With Identical Sequence